Cycling UK’s decision to exclude trans women from its 100 Women in Cycling list has sparked a wave of refusals, with several nominees rejecting their awards in protest against what they call a “step backwards for inclusion.”
The "ban" comes into force next month and applies to new prescriptions. Those already on them will remain on them.
"In a statement published on Wednesday afternoon, Health Minister Simeon Brown said Cabinet had agreed to the new settings until the outcome of a major clinical trial in the United Kingdom, expected in 2031.
The drugs - known as gonadotropin-releasing hormone analogues - would remain available for people already using them for gender dysphoria, as well as for medical conditions such as early-onset puberty, endometriosis, and prostate cancer.
Brown said the new rules - taking effect on 19 December - would give families confidence that any treatment was "clinically sound and in the best interests of the young person".
"These changes are about ensuring treatments are safe and carefully managed, while maintaining access to care for those who need it."
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.